Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1862-1868, 2006
DOI: 10.2337/db05-1049
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakanishi, K.
Right arrow Articles by Inoko, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakanishi, K.
Right arrow Articles by Inoko, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Combination of HLA-A24, -DQA1*03, and -DR9 Contributes to Acute-Onset and Early Complete ß-Cell Destruction in Type 1 Diabetes

Longitudinal Study of Residual ß-Cell Function

Koji Nakanishi1,2, and Hidetoshi Inoko3

1 Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan
2 Okinaka Memorial Institute for Medical Research, Tokyo, Japan
3 Department of Molecular Life Science, Division of Molecular Medical Science and Molecular Medicine, Tokai University Graduate School of Medicine, Kanagawa, Japan

Address correspondence and reprint requests to Koji Nakanishi, MD, PhD, Department of Endocrinology and Metabolism, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. E-mail: koji01{at}toranomon.gr.jp

Abbreviations: ADA, American Diabetes Association; CPR, C-peptide response; LADA, latent autoimmune diabetes of adults; RFLP, restriction fragment–length polymorphism

To elucidate the genetic factors contributing to heterogeneity of the rate of ß-cell destruction in type 1 diabetes, we investigated the relationship between the time course of complete ß-cell loss and HLA class I and II alleles. HLA allele frequencies were also examined among subgroups classified by the mode of onset. The subjects were 266 type 1 diabetic patients (among whom 196 patients were studied longitudinally) and 136 normal control subjects. Earlier complete loss of ß-cell function was observed in patients who possessed both HLA-A24 and HLA-DQA1*03 and in patients who had HLA-DR9, compared with those without these HLA alleles (P = 0.0057 and 0.0093, respectively). Much earlier complete ß-cell loss was observed in the patients who possessed all of HLA-A24, -DQA1*03, and -DR9 compared with the remaining patients (P = 0.0011). The combination of HLA-A24, -DQA1*03, and -DR9 showed a higher frequency in acute-onset than slow-onset type 1 diabetes (P = 0.0002). In contrast, HLA-DR2 was associated with a slower rate of progression to complete ß-cell loss. These results indicate that the combination of HLA-A24, -DQA1*03, and -DR9 contributes to the acute-onset and early complete ß-cell destruction, whereas HLA-DR2 has a protective effect against complete ß-cell loss in type 1 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.